Shoreline Biosciences Names Chief Business Officer
socalTECH
OCTOBER 12, 2021
San Diego-based biotechnology company Shoreline Biosciences said this morning that it has named Scott Forrest, Ph.D., as its Chief Business Officer. Forrest was most recently Chief Financial Officer at Autobahn Therapeutics, and also served at Inception Therapeutics, the Versant Ventures company building biotech companies. He also previously served at such companies at Lycia Therapeutics, Pipeline Therapeutics, Chinook Therapeutics and Ventus Therapeutics, among many others.
Let's personalize your content